• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » SpringFire adds Atherotech Diagnostics to its network

SpringFire adds Atherotech Diagnostics to its network

July 26, 2011
CenterWatch Staff

SpringFire Laboratory Network has reported the addition of Atherotech Diagnostics Lab to its network of affiliate laboratories, which provides specialized testing services to clinical trial sponsors and CROs.

The agreement adds Atherotech’s cardiometabolic testing services, including the patented VAP (Vertical Auto Profile) advanced lipid profile, to SpringFire’s offering.

Jim McClintic, managing partner of SpringFire Laboratory Network, said high complexity laboratories such as Atherotech are in great demand in the clinical trials market. They offer rapid turnaround times, competitive pricing and professional consultation on protocol development with clinical trials experience.

Atherotech offers researchers more than 50 cardiovascular and metabolic tests and is the only laboratory that performs the VAP Cholesterol Test, a directly measured assessment of all major lipoprotein classes (HDL, LDL, VLDL, IDL and Lp(a)) and their important subclasses, including HDL2, HDL3, LDL1-LDL4, apoB, apoA1 and the apoB/apoA1 ratio. The VAP profile also provides LDL subclass pattern (A, A/B or B) and remnant lipoprotein cholesterol.

“This partnership will further expose the VAP Test to the clinical trial marketplace,” said Michael Mullen, CEO of Atherotech.

With a combined menu of more than 1,000 specialty tests, SpringFire offers sponsors and CROs expertise and testing services in numerous therapeutic areas, including anatomical pathology, molecular genetics and women’s health.

Upcoming Events

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing